Poly(ADP-ribose) Polymerase Inhibitors Preserve Nicotinamide Adenine Dinucleotide and Adenosine 5'-triphosphate Pools in DNA-damaged Cells: Mechanism of Stimulation of Unscheduled DNA Synthesis
Overview
Authors
Affiliations
Inhibitors of poly(ADP-ribose) polymerase stimulated the level of DNA, RNA, and protein synthesis in DNA-damaged L1210 cells but had negligible effects in undamaged L1210 cells. The poly(ADP-ribose) polymerase inhibitors stimulated DNA repair synthesis after cells were exposed to high concentrations of N-methyl-N'-nitro-N-nitrosoguanidine (68 and 136 microM) but not after exposure to low concentrations (13.6 and 34 microM). When the L1210 cells were exposed to 136 microM N-methyl-N'-nitro-N-nitrosoguanidine, the activation of poly(ADP-ribose) polymerase resulted in the rapid depletion of oxidized nicotinamide adenine dinucleotide (NAD+) levels and subsequent depletion of adenosine 5'-triphosphate (ATP) pools. After low doses of N-methyl-N'-nitro-N-nitrosoguanidine (13.6 microM), there were only small decreases in NAD+ and ATP. Poly(ADP-ribose) polymerase inhibitors prevented the rapid fall in NAD+ and ATP pools. This preservation of the ATP pool has a permissive effect on energy-dependent functions and accounts for the apparent stimulation of DNA, RNA, and protein synthesis. Thus, the mechanism by which poly(ADP-ribose) polymerase inhibitors stimulate DNA, RNA, and protein synthesis in DNA-damaged cells appears to be mediated by their ability to prevent the drastic depletion of NAD+ pools that occurs in heavily damaged cells, thereby preserving the cells' ability to generate ATP and maintain energy-dependent processes.
Chia M, Bulat F, Gaunt A, Ros S, Wright A, Sawle A Oncogene. 2024; 44(9):563-574.
PMID: 39639170 PMC: 11850285. DOI: 10.1038/s41388-024-03231-w.
Song R, Yin S, Wu J, Yan J Neural Regen Res. 2024; 20(8):2245-2263.
PMID: 39104166 PMC: 11759035. DOI: 10.4103/NRR.NRR-D-24-00025.
Efficacy of Clinically Used PARP Inhibitors in a Murine Model of Acute Lung Injury.
Martins V, Santos S, Rodrigues L, Salomao R, Liaudet L, Szabo C Cells. 2022; 11(23).
PMID: 36497049 PMC: 9738530. DOI: 10.3390/cells11233789.
Determining the Potential of DNA Damage Response (DDR) Inhibitors in Cervical Cancer Therapy.
Saha S, Rundle S, Kotsopoulos I, Begbie J, Howarth R, Pappworth I Cancers (Basel). 2022; 14(17).
PMID: 36077823 PMC: 9454916. DOI: 10.3390/cancers14174288.
Poly(ADP-ribose) polymerase inhibition: past, present and future.
Curtin N, Szabo C Nat Rev Drug Discov. 2020; 19(10):711-736.
PMID: 32884152 DOI: 10.1038/s41573-020-0076-6.